Skip to main content

Advertisement

Fig. 3 | Trials

Fig. 3

From: Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36+ 0 weeks gestation

Fig. 3

Summary of assessments. aFor stillbirths or deaths, the SF-12™, GAD-2, Health Resource Use and Participant Views questionnaires are only sent where the participant has confirmed they wish to continue in the trial. bMidwife-Led Interviews are only to take place if the baby is still alive at the time of the interview, or for stillbirths and deaths where the participant has confirmed they wish to continue in the trial. csFlt-1/PlGF ratio blood test results will only be available at the time for participants in the intervention arm, not those in the control arm. dFor stillbirths and neonatal deaths prior to discharge, record cause of death, post-mortem findings and placental histology. Defined SAEs must be recorded from delivery to discharge from hospital for both the baby and participant. eDemographics e.g. gender, birthweight etc. fApgar scores to be recorded at 1 minute and 5 minutes after birth. gFor neonatal unit admissions, record reason for admission, duration of admission and number of dependency days

Back to article page